DRG 712: TESTES PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) - MARKET SIZE, PREVALENCE, INCIDENCE, QUALITY OUTCOMES, TOP HOSPITALS & PHYSICIANS
Want to know more about Dexur's Capabilities? Get In Touch
Jan 2013 to Dec 2017   |   Jan 2017 to Dec 2017
CHARGE CAPTURE ANALYSIS FOR DRG 712: TESTES PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) GROUP BASED ON MEDICARE | |
DEMOGRAPHIC DETAILS OF DRG 712: TESTES PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
Race |
Total Hospitalization Volume - Jan 2013 to Dec 2017 |
% of DRG Volume |
White |
647 |
75.06 |
Black |
141 |
16.36 |
Hispanic |
36 |
4.18 |
|
|
|
|
|
|
|
|
|
|
|
|
Age Group ( Years ) |
Total Hospitalization Volume - Jan 2013 to Dec 2017 |
% of DRG Volume |
Less than 65 |
244 |
28.31 |
65 to 69 |
187 |
21.69 |
70 to 74 |
161 |
18.68 |
|
|
|
|
|
|
|
|
|
TOP ICD DIAGNOSIS CODES FOR DRG 712: TESTES PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
TOP ICD PROCEDURE CODES FOR DRG 712: TESTES PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
TOP HOSPITALS ASSOCIATED WITH DRG 712: TESTES PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
DRG 712: TESTES PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) SUMMARY TABLE | |
Category |
Sub Category |
DRG Group |
ICD Codes |
ICD Description |
National Projected Hospitalizations (Present on Admission - All) Jan 2016 to Dec 2016 |
Medicare Hospitalizations (Present on Admission - All) Jan 2013 to Dec 2017 |
National Projected Hospitalizations(Present on Admission - Yes) Jan 2016 to Dec 2016 |
Medicare Hospitalizations (Present on Admission - Yes) Jan 2013 to Dec 2017 |
National Projected Hospitalizations (Present on Admission - Not Y) Jan 2016 to Dec 2016 |
Medicare Hospitalizations (Present on Admission - Not Y) Jan 2013 to Dec 2017 |
Total Discharges After Exclusion |
Avg. LOS |
GMLOS |
All Cause Readmission Rate (%) |
Unplanned Readmission Rate (%) |
Total Medicare Payments |
Payment per Day |
Payment per Discharge |
Total Medicare Charges |
Avg. Charges |
Mortality Rate (%) |
SNF Discharge Rate (%) |
Home Discharge Rate (%) |
Urology |
Testes Procedures |
Testes Procedures |
4019 |
Unspecified essential hypertension |
NA |
280 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Urology |
Testes Procedures |
Testes Procedures |
I10 |
Essential (primary) hypertension |
416 |
170 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Urology |
Testes Procedures |
Testes Procedures |
2724 |
Other and unspecified hyperlipidemia |
NA |
142 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Urology |
Testes Procedures |
Testes Procedures |
25000 |
Diabetes mellitus without mention of complication, type II or unspecified type, not stated as uncontrolled |
NA |
135 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Urology |
Testes Procedures |
Testes Procedures |
6039 |
Hydrocele, unspecified |
NA |
134 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Urology |
Testes Procedures |
Testes Procedures |
N433 |
Hydrocele, unspecified |
522 |
93 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Urology |
Testes Procedures |
Testes Procedures |
E785 |
Hyperlipidemia, unspecified |
204 |
88 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Urology |
Testes Procedures |
Testes Procedures |
53081 |
Esophageal reflux |
NA |
87 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Urology |
Testes Procedures |
Testes Procedures |
6084 |
Other inflammatory disorders of male genital organs |
NA |
85 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Urology |
Testes Procedures |
Testes Procedures |
3051 |
Tobacco use disorder |
NA |
80 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|